These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13849740)

  • 1. Properties of Mycobacterium tuberculosis strains resistant to izoniazid hydrazin (INH).
    EYLAN E; BRACHFELD R
    Bull Res Counc Isr Sect E Exp Med; 1959 Oct; 8E():40-1. PubMed ID: 13849740
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study of the mechanism of appearance of INH resistance. I. The isolation of INH-resistant strains which require certain growth-supporting factors and these supporting factors].
    KOGA T
    Kekkaku; 1960 Feb; 35():113-7. PubMed ID: 14410498
    [No Abstract]   [Full Text] [Related]  

  • 3. [On certain immuno-biological characteristics of INH-resistant strains].
    GARBINSKI T
    Gruzlica (1926); 1959 Jul; 27():653-7. PubMed ID: 13826384
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long term evolution of characters of strains of "isoniazid-resistant" Mycobacterium tuberculosis].
    VIALLIER J; CAYRE RM; AUGAGNEUR J
    C R Seances Soc Biol Fil; 1960; 154():655-6. PubMed ID: 13781115
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relation of bacterial growth factors and of their antagonists to the mechanism of action of INH on Mycobacterium tuberculosis].
    KUBALA E; KUBALOVA J
    Cesk Epidemiol Mikrobiol Imunol; 1961 Jan; 10():48-56. PubMed ID: 13754741
    [No Abstract]   [Full Text] [Related]  

  • 6. [Structure of INH-resistant variants of the BCG-Paris strain. Isolation, culture and production of INH-resistant catalase-positive and catalase-negative mutants with a view toward vaccination].
    AUGIER J; BRETEY J; KOSLOFF-SENECHAL F
    Ann Inst Pasteur (Paris); 1962 Aug; 103():185-200. PubMed ID: 13863251
    [No Abstract]   [Full Text] [Related]  

  • 7. [The characteristic resistance of Mycobacterium and its role played in the development of acquired resistance to antituberculous agents. 4. Natural resistance to SM and INH and the development of acquired resistance].
    YAMADA O
    Kekkaku; 1959 Dec; 34():823-9. PubMed ID: 13846375
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new method of examining the bacteriostatic effect of INH in microbiological assay for INH concentration in human serum].
    YAMAMOTO Y; SAKAMOTO Y
    Kekkaku; 1961 Feb; 36():88-93. PubMed ID: 13787160
    [No Abstract]   [Full Text] [Related]  

  • 9. [The characteristic resistance of mycobacteria and its role played in the development of acquired resistance to antituberculous agents. 5. Resistance to SM and INH of the cells in the suspensions of mycobacteria and the development of the acquired resistance in these cells].
    YAMADA O
    Kekkaku; 1960 Jan; 35():1-5. PubMed ID: 13846378
    [No Abstract]   [Full Text] [Related]  

  • 10. [The development of sensitivity to streptomycin, PAS and isoniazid of strains of "Mycobacterium tuberculosis" isolated from human pathological products between 1953 and 1960].
    VIALLIER J; CAYRE RM; AUGAGNEUR J
    Ann Biol Clin (Paris); 1961; 19():411-8. PubMed ID: 13781116
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of 58 titrations of sensitivity to streptomycin, PAS and isoniazid of Mycobacterium tuberculosis].
    BURDIN JC; SCHMITT J; de LAVERGNE ; BRIQUEL P; RIBAR D
    Rev Med Nancy; 1960 Feb; 85():131-5. PubMed ID: 13806020
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on the Welsch phenomenon in the course of research conducted on various strains of M. tuberculosis].
    CHIGNOLI V
    Acta Med Ital Mal Infett Parassit; 1960; 15():133-8. PubMed ID: 13878955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent data on isoniazid resistance].
    DELAUDE A
    Poumon Coeur; 1961; 17():543-54. PubMed ID: 13885073
    [No Abstract]   [Full Text] [Related]  

  • 14. Further mutational studies on the isoniazid resistance of Mycobacterium tuberculosis.
    TSUKAMURA M
    Jpn J Microbiol; 1960 Apr; 4():115-22. PubMed ID: 13778445
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of catalase in the blood and organs during the course of INH therapy of guinea pigs infected with strains of Mycobacterium tuberculosis resistant to INH and sensitive to INH].
    MASZCZYK Z; PIEKARNIAK K
    Gruzlica (1926); 1960 Jan; 28():11-8. PubMed ID: 14422212
    [No Abstract]   [Full Text] [Related]  

  • 16. [Demonstration of sporadic isoniazid-sensitive colonies in a primarily isoniazid-resistant culture with the aid of peroxidase tests].
    VISCHER WA; TIRUNARAYANAN MO; BRUHIN H
    Schweiz Z Tuberc Pneumonol; 1959; 16():415-8. PubMed ID: 13842454
    [No Abstract]   [Full Text] [Related]  

  • 17. Decrease of bacteriotropic activity of isoniazid on M. tuberculosis in the presence of anthranilic acid.
    SIMANE Z; URBANCIK R
    Experientia; 1960 Apr; 16():148-9. PubMed ID: 14446808
    [No Abstract]   [Full Text] [Related]  

  • 18. Pigments produced by mycobacteria on exposure to isoniazid.
    YOUATT J
    Aust J Exp Biol Med Sci; 1961 Feb; 39():93-100. PubMed ID: 13787422
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of isoniazid on the dehydrogenase activity of Mycobacterium tuberculosis.
    SCHAEFER WB
    J Bacteriol; 1960 Feb; 79(2):236-45. PubMed ID: 14442361
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of gene chip in detecting Mycobacterium tuberculosis resistant to rifampin and isoniazid].
    Cui ZL; Jing FX; Hu ZY; Wu ZR; Zhao JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):439-41. PubMed ID: 15312553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.